Clinical trial Recruiting at 2 sites Interventional Ages 40 to 75

Acute intermittent hypercapnia-based interventions for upper airway and axial control in Parkinsonism

Official title: A Pilot Study of Acute Intermittent Hypercapnia-Based Interventions on Upper Airway and Axial Motor Function in Parkinson's Disease

Run by University of Florida · NCT07674264 · Data updated 2026-11-12

This randomized pilot study tests whether a single session of acute intermittent hypercapnic hypoxia or hypercapnic normoxia can improve upper airway and axial motor function in adults with Parkinsonism.

Quick facts

Study typeInterventional
Ages40 Years to 75 Years
SexAll
Enrollment32 (estimated)
SponsorUniversity of Florida
Academic / other
Locations2 sites (Gainesville, Florida and 1 other locations)
StatusRecruiting
StartedAugust 12, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedAugust 21, 2026
Trial IDNCT07674264 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40–75 with idiopathic Parkinsonism (Hoehn and Yahr stages 2–4), medically stable, able to walk at least 10 feet, and able to follow directions.

Probably not a fit

Individuals with additional neurologic conditions, uncontrolled cardiovascular issues, or deep brain stimulation implants may not benefit or participate safely.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional pilot trial explores whether brief exposure to controlled levels of CO2-related breathing challenges can improve breathing-related and axial motor function in Parkinsonism. Participants will be randomized to receive either acute intermittent hypercapnic hypoxia (AIHH) or acute intermittent hypercapnic normoxia (AIHN) in a single session. The study looks for changes in upper airway control, axial motor performance, and related biomarkers to understand who may respond best. Safety monitoring and feasibility of this approach will also be evaluated. The trial is conducted at the University of Florida and the Norman Fixel Institute, with adults aged 40 to 75 years who have idiopathic Parkinsonism and meet eligibility criteria.

Why it matters

Potential benefit: If successful, the intervention could improve breathing, speech volume, and cough effectiveness in people with Parkinsonism.

How similar studies have gone: Prior work in related respiratory-nerve and motor-function domains has shown feasibility with hypercapnic interventions, but this exact protocol for Parkinsonism is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. adults 40 to 75 years of age (the latter to reduce the likelihood of cardiovascular disease)
2. diagnosis of idiopathic Parkinsonism with Hoehn and Yahr stages 2-4
3. medically stable with physician clearance
4. ability to ambulate at least 10 feet with/without assistance
5. ability to follow directions
6. willing to abstain from blood donation for the duration of the study

Exclusion Criteria:

1. additional neurologic conditions
2. severe illness or infection, including respiratory/cardiovascular/lung disease, or uncontrolled hypertension
3. inspiratory stridor
4. pregnancy due to unknown tAIH effects on a fetus, although females of childbearing age will not be excluded\*
5. cigarette smoking or vaping within 5 years
6. history of head/neck/lung cancer with the exception of basal cell carcinoma
7. is currently participating in another research study that could influence the results from this study
8. has deep brain stimulation electrodes implanted or has a history of deep brain stimulation
9. faints or becomes lightheaded at the sight of blood

   * If a female of childbearing potential indicates there is a chance she could be pregnant, she will be provided a pregnancy test and allowed to continue in the study if negative. This is because the fetal risks associated with intermittent hypoxia are unknown.

Where it's running

  • University of Florida
    Gainesville, Florida, United States
    Recruiting
  • Norman Fixel Institute for Neurological Diseases
    Gainesville, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Michela Mir, CCC-SLP — University of Florida
  • Study coordinator: Michlela Mir, CCC-SLP, PhD
  • Email: michela.mir@ufl.edu
  • Phone: 352-273-6095

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.